HCA Healthcare Inc (NYSE:HCA) has earned an average rating of “Hold” from the twenty-six research firms that are presently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a sell rating, six have given a hold rating and sixteen have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $107.29.
HCA has been the topic of a number of research reports. Zacks Investment Research cut HCA Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, March 20th. Mizuho initiated coverage on HCA Healthcare in a report on Friday, March 23rd. They issued a “buy” rating and a $115.00 price target on the stock.
In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,750 shares of the stock in a transaction on Wednesday, June 13th. The stock was sold at an average price of $106.87, for a total transaction of $187,022.50. Following the transaction, the senior vice president now owns 9,494 shares of the company’s stock, valued at approximately $1,014,623.78. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jonathan B. Perlin sold 11,520 shares of the stock in a transaction on Thursday, May 17th. The stock was sold at an average price of $104.00, for a total value of $1,198,080.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 39,474 shares of company stock worth $4,161,523. Corporate insiders own 2.80% of the company’s stock.
HCA opened at $105.68 on Monday. The company has a market capitalization of $37.18 billion, a P/E ratio of 16.04, a PEG ratio of 1.04 and a beta of 0.51. The company has a debt-to-equity ratio of -7.13, a quick ratio of 1.17 and a current ratio of 1.39. HCA Healthcare has a 1-year low of $71.18 and a 1-year high of $107.37.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, May 1st. The company reported $2.33 earnings per share for the quarter, topping analysts’ consensus estimates of $2.07 by $0.26. The business had revenue of $11.42 billion for the quarter, compared to analysts’ expectations of $11.29 billion. HCA Healthcare had a negative return on equity of 55.50% and a net margin of 5.96%. The company’s revenue was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.74 EPS. equities research analysts forecast that HCA Healthcare will post 8.83 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, June 29th. Investors of record on Friday, June 1st will be paid a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend is Thursday, May 31st. HCA Healthcare’s payout ratio is currently 21.24%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.